Biomarker detection in pulmonary hypertension

Abstract

The present disclosure relates to methods of identifying miRNAs in patients with pulmonary hypertension, subjecting the patients to therapy, and monitoring disease progression by analyzing miRNAs expression levels. The present disclosure also relates to methods of identifying miRNA profiles in a subject to determine whether the subject is suffering from pulmonary hypertension or is at risk of developing pulmonary hypertension.

Dependencies are inferred from the claim text.